Go to content
UR Home

Adequate nephroprotection reduces renal complications after hyperthermic intrathoracic chemotherapy

URN to cite this document:
DOI to cite this document:
Markowiak, Till Marvin ; Kerner, Nadine ; Neu, Reiner ; Potzger, Tobias ; Großer, Christian ; Zeman, Florian ; Hofmann, Hans‐Stefan ; Ried, Michael
License: Creative Commons: Attribution 3.0
PDF - Published Version
Date of publication of this fulltext: 31 Mar 2021 15:33

This publication is part of the DEAL contract with Wiley.


Background and Objectives Hyperthermic intrathoracic chemotherapy (HITOC) is used for the treatment of malignant pleural tumors. Although HITOC proved to be safe, postoperative renal failure due to nephrotoxicity of intrapleural cisplatin remains a concern. Methods This single-center study was performed retrospectively in patients who underwent pleural tumor resection and HITOC between September ...


Owner only: item control page
  1. Homepage UR

University Library

Publication Server


Publishing: oa@ur.de
0941 943 -4239 or -69394

Dissertations: dissertationen@ur.de
0941 943 -3904

Research data: datahub@ur.de
0941 943 -5707

Contact persons